Showing results (2421-2430 of 3,440) with videos related to

Sort By:
Pageof 344
Annales De Cardiologie Et D'Angeiologie|October 21, 2015
[Diagnosis of a systolic murmur among young asymptomatic patient: An assessment of professional practices for the expertise in military medicine]M-C Boeuf, G Rohel, G Lamour, et al.
Annals of Surgical Oncology|May 26, 2018
Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center StudyI Sourrouille, R Macovei, M Faron, et al.
Annales De Cardiologie Et D'Angeiologie|November 1, 1983
[Cardiac complications of radiotherapy]A Vacheron, A Heulin, J P Metzger, et al.
Immunogenetics|January 1, 1995
Structural analysis of the RH-like blood group gene products in nonhuman primatesI Salvignol, P Calvas, W W Socha, et al.
British Journal of Cancer|January 20, 2006
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancerC Le Page, V Ouellet, J Madore, et al.
Breast Cancer Research and Treatment|January 1, 1996
Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot studyS M Scholl, R Lidereau, A de la Rochefordière, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1991
[Prognosis of ischemic mitral valve insufficiency]C Le Feuvre, M L Lachurié, J L Georges, et al.
Journal of Science and Medicine in Sport|April 5, 2015
Using platelet-rich plasma to treat jumper's knees: Exploring the effect of a second closely-timed infiltrationJ F Kaux, J L Croisier, B Forthomme, et al.
Journal of Virology|July 25, 2000
Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytesV Molinier-Frenkel, H Gahery-Segard, M Mehtali, et al.
Leukemia & Lymphoma|June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphomaG Cartron, L Voillat, B Desablens, et al.
Pageof 344